Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Martin (Palma, Spain). LSC - 2020 - Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis patients. 456

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021 Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020 LSC - 2021 - Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 PP238 – Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis Source: ERS Lung Science Conference 2021 Year: 2021 Results immunophenotyping cultured autologous mesenchymal stromal cell of patients with COPD and IPF in Belarus Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases Year: 2015 LSC - 2021 - A comprehensive guide to pulmonary mesenchymal populations in the healthy and IPF lung. Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair Year: 2021 Late Breaking Abstract - High cumulative dose of allogeneic mesenchymal stem cells in patients with progressive idiopathic pulmonary fibrosis Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Abnormal proliferation and differentiation of c-kit+ lung stem cells in pulmonary fibrosis Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 Impaired migration of bone marrow mesenchymal stem cells in COPD Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Expression of the biological axis VEGF-CXCL12/CXCR4 in bone marrow mesenchymal stem cells (BM MSCs) in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis Year: 2008 PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids Source: ERS Lung Science Conference 2021 Year: 2021 Oral presentation: Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 Increased CXCR4 expression and short telomeres in bone marrow mesenchymal stem cells of patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009 In search of ckit+ stem cells in lung tissue Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema Year: 2015 YI04 - Recruitment of stem cell populations to the lung with disease Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration Year: 2012 Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease Year: 2015 LSC 2010 Abstract: Does cigarette smoking influence bone marrow microenvironment? Down-regulation of CXCR4 expression in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): preliminary results Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010 Increased TERT mRNA expression of bone marrow mesenchymal stem cells (BM-MSCs) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury Source: Eur Respir J 2009; 34: 740 Year: 2009 Epithelial stem cells at the intersection of tissue regeneration and pulmonary fibrosis Source: Eur Respir Monogr 2021; 91: 290-305 Year: 2021